Multiplex PCR versus Respiratory Culture for Pediatric Lower Respiratory Tract Infection: Diagnostic Yield and Antibiotic Stewardship Impact in a UAE Tertiary Hospital

Background: Lower respiratory tract infections (LRTIs) are a leading cause of pediatric morbidity and mortality worldwide. Conventional respiratory culture, the traditional diagnostic standard, is limited by prolonged turnaround times and reduced sensitivity, particularly in patients who have already received antibiotics. The BioFire FilmArray Pneumonia Panel (FA-Pneumo), a multiplex polymerase chain reaction (PCR) assay, offers rapid, semi-quantitative pathogen detection, but data on its diagnostic performance and antibiotic stewardship impact in hospitalized children remain limited, particularly in the Middle East.

Methods: We conducted a retrospective cohort study at a tertiary pediatric hospital in Dubai, United Arab Emirates, including 150 hospitalized children (aged 0–18 years) with suspected LRTIs who underwent simultaneous FA-Pneumo PCR and respiratory culture testing between December 2022 and December 2025. Diagnostic yield, PCR-culture agreement, and antibiotic management changes following PCR and culture results were analyzed. Sensitivity and specificity were calculated using culture as the reference standard. Agreement between PCR semi-quantitative copy number levels and culture growth intensity was assessed using Cohen’s kappa.

Results: PCR demonstrated a positivity rate of 90.0% compared to 59.3% for culture, with a sensitivity of 90.5% and specificity of 45.9% against culture as the reference standard. Median turnaround time was 3 hours for PCR versus 72 hours for culture. Agreement between PCR copy number levels and culture growth intensity was statistically significant but modest, ranging from fair to slight in magnitude (Cohen’s kappa = 0.223 and 0.113, p<0.001). PCR detections at the highest copy level (10⁶–10⁷ copies/mL) corresponded to heavy culture growth in 67.6% of cases, while 50.0% of detections at the lowest positive level (10⁴ copies/mL) were associated with negative cultures. PCR results prompted antibiotic management changes in 56 of 150 patients (37.3%), predominantly escalation (19.3%), while culture results drove modifications in 88 patients (58.7%), predominantly targeted therapy or de-escalation (44.7%).

Conclusions: The FA-Pneumo PCR demonstrated substantially higher diagnostic yield and faster turnaround than respiratory culture in hospitalized pediatric patients with suspected LRTI. PCR-culture agreement was modest, supporting their use as complementary rather than interchangeable diagnostic tools, with higher PCR copy number levels more reliably indicating true active infection. The stewardship potential of PCR remains incompletely realized in routine practice, highlighting the need for institution-specific PCR-guided antibiotic stewardship protocols in tertiary pediatric care settings. This study contributes pediatric-specific data from the Middle East, a region in which such evidence remains scarce.